341 related articles for article (PubMed ID: 12147034)
1. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
[TBL] [Abstract][Full Text] [Related]
2. Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screening.
Cuijpers HT; Molijn MH; Bos HJ; Peeters AP; van der Poel CL; Lelie PN
Vox Sang; 2001 Jul; 81(1):12-20. PubMed ID: 11520410
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of HCV RNA and HIV RNA blood screening assays.
Lelie PN; van Drimmelen HA; Cuypers HT; Best SJ; Stramer SL; Hyland C; Allain JP; Moncharmont P; Defer C; Nübling M; Glauser A; da Silva Cardoso M; Viret JF; Lankinen MH; Grillner L; Wirthmüller U; Coste J; Schottstedt V; Masecar B; Dax EM
Transfusion; 2002 May; 42(5):527-36. PubMed ID: 12084160
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
[TBL] [Abstract][Full Text] [Related]
6. European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.
Cuypers HT; van Dijk R; Viret JF; Schottstedt V; Lankinen M; Da Silva Cardoso M; Lelie PN
Biologicals; 1999 Dec; 27(4):303-14. PubMed ID: 10686057
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of automated nucleic acid extraction devices for application in HCV NAT.
Jongerius JM; Bovenhorst M; van der Poel CL; van Hilten JA; Kroes AC; van der Does JA; van Leeuwen EF; Schuurman R
Transfusion; 2000 Jul; 40(7):871-4. PubMed ID: 10924618
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
[TBL] [Abstract][Full Text] [Related]
9. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
Palomäki P; Wessberg S; Tuomi K; Laitinen H
Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
[TBL] [Abstract][Full Text] [Related]
10. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.
Candotti D; Richetin A; Cant B; Temple J; Sims C; Reeves I; Barbara JA; Allain JP
Transfusion; 2003 Feb; 43(2):215-25. PubMed ID: 12559017
[TBL] [Abstract][Full Text] [Related]
12. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
[TBL] [Abstract][Full Text] [Related]
13. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
Nübling CM; Unkelbach U; Chudy M; Seitz R
Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
[TBL] [Abstract][Full Text] [Related]
15. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood.
Sun R; Schilling W; Jayakar H; Ku J; Wang J; Rosenstraus M; Spadoro J
Transfusion; 1999 Oct; 39(10):1111-9. PubMed ID: 10532606
[TBL] [Abstract][Full Text] [Related]
17. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.
Roth WK; Weber M; Buhr S; Drosten C; Weichert W; Sireis W; Hedges D; Seifried E
Transfusion; 2002 Jul; 42(7):862-8. PubMed ID: 12375658
[TBL] [Abstract][Full Text] [Related]
18. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.
Ohnuma H; Tanaka T; Yoshikawa A; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Tomono T; Murozuka T; Takeda Y; Doi Y; Mine H; Yokoyama S; Hirose T; Nishioka K;
Microbiol Immunol; 2001; 45(9):667-72. PubMed ID: 11694079
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies.
Mison L; Seed CR; Margaritis AR; Hyland C;
Vox Sang; 2003 Jan; 84(1):11-9. PubMed ID: 12542729
[TBL] [Abstract][Full Text] [Related]
20. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
